[HTML][HTML] Engineered bacteriophage therapeutics: rationale, challenges and future
M Łobocka, K Dąbrowska, A Górski - BioDrugs, 2021 - Springer
The current problems with increasing bacterial resistance to antibacterial therapies, resulting
in a growing frequency of incurable bacterial infections, necessitates the acceleration of …
in a growing frequency of incurable bacterial infections, necessitates the acceleration of …
[HTML][HTML] Acinetobacter baumannii Bacteriophage: Progress in Isolation, Genome Sequencing, Preclinical Research, and Clinical Application
Y Li, S Xiao, G Huang - Current Microbiology, 2023 - Springer
Acinetobacter baumannii (A. baumannii) is a common nosocomial pathogen associated with
serious clinical challenges owing to its rapidly increasing resistance to antibiotics. Due to …
serious clinical challenges owing to its rapidly increasing resistance to antibiotics. Due to …
[HTML][HTML] Characterization of a novel and active temperate phage vB_AbaM_ABMM1 with antibacterial activity against Acinetobacter baumannii infection
M Mardiana, SH Teh, YC Tsai, HH Yang, LC Lin… - Scientific Reports, 2023 - nature.com
Acinetobacter baumannii is an opportunistic pathogen that significantly causes hospital-
acquired infections. Due to its multidrug resistance, treating infections caused by this …
acquired infections. Due to its multidrug resistance, treating infections caused by this …
[HTML][HTML] An ensemble method for prediction of phage-based therapy against bacterial infections
Phage therapy is a viable alternative to antibiotics for treating microbial infections,
particularly managing drug-resistant strains of bacteria. One of the major challenges in …
particularly managing drug-resistant strains of bacteria. One of the major challenges in …
[HTML][HTML] Biological Properties of 12 Newly Isolated Acinetobacter baumannii-Specific Bacteriophages
N Bagińska, MA Harhala, M Cieślik, F Orwat… - Viruses, 2023 - mdpi.com
Infections with the opportunistic Gram-negative bacterium Acinetobacter baumannii pose a
serious threat today, which is aggravated by the growing problem of multi-drug resistance …
serious threat today, which is aggravated by the growing problem of multi-drug resistance …
[HTML][HTML] Acinetobacter baumannii: More ways to die
GK Oyejobi, SO Olaniyan, NA Yusuf… - Microbiological …, 2022 - Elsevier
Acinetobacter baumannii is an important nosocomial and opportunistic pathogen. It causes
infections worldwide, especially in intensive care units. It is clinically significant owing to its …
infections worldwide, especially in intensive care units. It is clinically significant owing to its …
Isolation and genome-wide analysis of the novel Acinetobacter baumannii bacteriophage vB_AbaM_AB3P2
Y Tan, J Su, D Luo, B Liang, S Liu, H Zeng - Archives of Virology, 2024 - Springer
A lytic Acinetobacter baumannii phage, isolate vB_AbaM_AB3P2, was isolated from a
sewage treatment plant in China. A. baumannii phage vB_AbaM_AB3P2 has a dsDNA …
sewage treatment plant in China. A. baumannii phage vB_AbaM_AB3P2 has a dsDNA …
Isolation and genomic analysis of temperate phage 5W targeting multidrug-resistant Acinetobacter baumannii
W Peng, F Zeng, Z Wu, Z Jin, W Li, M Zhu… - Archives of …, 2022 - Springer
Temperate phages are potential therapeutic agents, but only a few temperate phages
infecting multidrug-resistant Acinetobacter baumannii have been identified. In this study, we …
infecting multidrug-resistant Acinetobacter baumannii have been identified. In this study, we …
A plethora of carbapenem resistance in Acinetobacter baumannii: no end to a long insidious genetic journey
Acinetobacter baumannii, notorious for causing nosocomial infections especially in patients
admitted to intensive care unit (ICU) and burn units, is best at displaying resistance to all …
admitted to intensive care unit (ICU) and burn units, is best at displaying resistance to all …
[HTML][HTML] Characterization of a Novel Phage ΦAb1656-2 and Its Endolysin with Higher Antimicrobial Activity against Multidrug-Resistant Acinetobacter baumannii
Acinetobacter baumannii is a nosocomial pathogen, which is a problem worldwide due to
the emergence of a difficult-to-treat multidrug-resistant A. baumannii (MDRAB). Endolysins …
the emergence of a difficult-to-treat multidrug-resistant A. baumannii (MDRAB). Endolysins …